Skip to content

A multicenter randomized clinical trial of the clinical effects of YGCu300, TCu380A, and Medicated ring 165 inserted during lactation (from 6 weeks to 6 months postpartum) in China

A multicenter randomized clinical trial of the clinical effects of YGCu300, TCu380A, and Medicated ring 165 inserted during lactation (from 6 weeks to 6 months postpartum) in China

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005702
Enrollment
Unknown
Registered
2014-12-22
Start date
2007-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contraception

Interventions

1:YGCu300
3:Medicated ring 165

Sponsors

National Research Institute for Family Planning
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: To be eligible for enrolment, lacation women had to be healthy; To be aged from 20 years to 45 years; having had given birth before; having normal monthly bleeding (menstruation cycle was 21 to 42 days and regular, and menstrual period was less than 7 days); no irregular bleeding and no hydatidiform mole; uterine cavity was 5.5 to 9.0 cm (not include cesarean); having hemoglobin above 90 kilos per liter; having regular sex; relying solely on the IUD for fertility regulation; informed and agreed to take part in the study.

Exclusion criteria

Exclusion criteria: Contraindications included pregnancy, uterine abnormalities, evidence of vaginal or pelvic infections, uterine cavity length longer than 9 cm, cervical neoplasia, anemia.

Design outcomes

Primary

MeasureTime frame
pregnancy;pregnancy;expulsions;all medical removals;use-related discontinuation;

Countries

China

Contacts

Public ContactWu Shangchun
wu.shang.chun@yeah.net+86 13801131787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026